nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—Methimazole—Graves' disease	0.34	0.421	CbGbCtD
Mianserin—CYP1A2—Methimazole—Graves' disease	0.2	0.247	CbGbCtD
Mianserin—CYP2D6—Methimazole—Graves' disease	0.164	0.203	CbGbCtD
Mianserin—CYP3A4—Methimazole—Graves' disease	0.105	0.129	CbGbCtD
Mianserin—Drowsiness—Methimazole—Graves' disease	0.00766	0.0484	CcSEcCtD
Mianserin—Jaundice—Methimazole—Graves' disease	0.00747	0.0471	CcSEcCtD
Mianserin—Agranulocytosis—Methimazole—Graves' disease	0.00715	0.0451	CcSEcCtD
Mianserin—Hepatitis—Methimazole—Graves' disease	0.00688	0.0434	CcSEcCtD
Mianserin—Drowsiness—Propylthiouracil—Graves' disease	0.00651	0.0411	CcSEcCtD
Mianserin—Jaundice—Propylthiouracil—Graves' disease	0.00635	0.0401	CcSEcCtD
Mianserin—Agranulocytosis—Propylthiouracil—Graves' disease	0.00608	0.0384	CcSEcCtD
Mianserin—Hepatitis—Propylthiouracil—Graves' disease	0.00585	0.0369	CcSEcCtD
Mianserin—Vertigo—Methimazole—Graves' disease	0.00538	0.034	CcSEcCtD
Mianserin—Leukopenia—Methimazole—Graves' disease	0.00536	0.0338	CcSEcCtD
Mianserin—Arthralgia—Methimazole—Graves' disease	0.0051	0.0322	CcSEcCtD
Mianserin—Myalgia—Methimazole—Graves' disease	0.0051	0.0322	CcSEcCtD
Mianserin—Oedema—Methimazole—Graves' disease	0.00489	0.0308	CcSEcCtD
Mianserin—Thrombocytopenia—Methimazole—Graves' disease	0.00478	0.0302	CcSEcCtD
Mianserin—Vertigo—Propylthiouracil—Graves' disease	0.00457	0.0289	CcSEcCtD
Mianserin—Leukopenia—Propylthiouracil—Graves' disease	0.00456	0.0288	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00445	0.0281	CcSEcCtD
Mianserin—Paraesthesia—Methimazole—Graves' disease	0.00439	0.0277	CcSEcCtD
Mianserin—Somnolence—Methimazole—Graves' disease	0.00434	0.0274	CcSEcCtD
Mianserin—Myalgia—Propylthiouracil—Graves' disease	0.00433	0.0274	CcSEcCtD
Mianserin—Arthralgia—Propylthiouracil—Graves' disease	0.00433	0.0274	CcSEcCtD
Mianserin—Oedema—Propylthiouracil—Graves' disease	0.00415	0.0262	CcSEcCtD
Mianserin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00407	0.0257	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00378	0.0239	CcSEcCtD
Mianserin—Paraesthesia—Propylthiouracil—Graves' disease	0.00373	0.0236	CcSEcCtD
Mianserin—Somnolence—Propylthiouracil—Graves' disease	0.00369	0.0233	CcSEcCtD
Mianserin—Pruritus—Methimazole—Graves' disease	0.00346	0.0218	CcSEcCtD
Mianserin—Rash—Methimazole—Graves' disease	0.00308	0.0194	CcSEcCtD
Mianserin—Dermatitis—Methimazole—Graves' disease	0.00308	0.0194	CcSEcCtD
Mianserin—Headache—Methimazole—Graves' disease	0.00306	0.0193	CcSEcCtD
Mianserin—Pruritus—Propylthiouracil—Graves' disease	0.00294	0.0186	CcSEcCtD
Mianserin—Rash—Propylthiouracil—Graves' disease	0.00262	0.0165	CcSEcCtD
Mianserin—Dermatitis—Propylthiouracil—Graves' disease	0.00262	0.0165	CcSEcCtD
Mianserin—Headache—Propylthiouracil—Graves' disease	0.0026	0.0164	CcSEcCtD
Mianserin—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000133	0.00409	CbGpPWpGaD
Mianserin—HRH4—GPCR ligand binding—CXCL10—Graves' disease	0.00013	0.00402	CbGpPWpGaD
Mianserin—OPRK1—G alpha (i) signalling events—CXCL10—Graves' disease	0.00013	0.004	CbGpPWpGaD
Mianserin—HTR1D—G alpha (i) signalling events—CXCL10—Graves' disease	0.000127	0.00392	CbGpPWpGaD
Mianserin—SLC6A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000126	0.00387	CbGpPWpGaD
Mianserin—OPRK1—GPCR ligand binding—TSHR—Graves' disease	0.000122	0.00375	CbGpPWpGaD
Mianserin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000121	0.00372	CbGpPWpGaD
Mianserin—HTR1F—GPCR ligand binding—CXCL10—Graves' disease	0.00012	0.00371	CbGpPWpGaD
Mianserin—HTR6—GPCR ligand binding—TSHR—Graves' disease	0.00012	0.0037	CbGpPWpGaD
Mianserin—HTR7—GPCR ligand binding—TSHR—Graves' disease	0.00012	0.00369	CbGpPWpGaD
Mianserin—HTR1D—GPCR ligand binding—TSHR—Graves' disease	0.000119	0.00367	CbGpPWpGaD
Mianserin—SLC6A4—Circadian rythm related genes—FAS—Graves' disease	0.000118	0.00365	CbGpPWpGaD
Mianserin—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000117	0.00359	CbGpPWpGaD
Mianserin—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000116	0.00358	CbGpPWpGaD
Mianserin—HRH4—GPCR downstream signaling—TSHR—Graves' disease	0.000114	0.00351	CbGpPWpGaD
Mianserin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000113	0.00348	CbGpPWpGaD
Mianserin—HTR7—Circadian rythm related genes—FAS—Graves' disease	0.000111	0.00343	CbGpPWpGaD
Mianserin—SLC6A3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000111	0.00343	CbGpPWpGaD
Mianserin—HTR2B—GPCR ligand binding—TSHR—Graves' disease	0.000109	0.00337	CbGpPWpGaD
Mianserin—DRD3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000109	0.00335	CbGpPWpGaD
Mianserin—HTR1F—GPCR downstream signaling—TSHR—Graves' disease	0.000105	0.00324	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—TSHR—Graves' disease	0.000103	0.00319	CbGpPWpGaD
Mianserin—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000103	0.00318	CbGpPWpGaD
Mianserin—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000102	0.00316	CbGpPWpGaD
Mianserin—DRD3—GPCR ligand binding—TSHR—Graves' disease	0.000102	0.00314	CbGpPWpGaD
Mianserin—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000102	0.00314	CbGpPWpGaD
Mianserin—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000102	0.00313	CbGpPWpGaD
Mianserin—HRH2—GPCR ligand binding—CXCL10—Graves' disease	0.000101	0.00312	CbGpPWpGaD
Mianserin—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000101	0.00311	CbGpPWpGaD
Mianserin—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000101	0.0031	CbGpPWpGaD
Mianserin—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.0001	0.0031	CbGpPWpGaD
Mianserin—ADRA2B—G alpha (i) signalling events—CXCL10—Graves' disease	9.81e-05	0.00303	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—TSHR—Graves' disease	9.55e-05	0.00294	CbGpPWpGaD
Mianserin—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	9.47e-05	0.00292	CbGpPWpGaD
Mianserin—DRD3—Circadian rythm related genes—FAS—Graves' disease	9.47e-05	0.00292	CbGpPWpGaD
Mianserin—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	9.29e-05	0.00286	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—TSHR—Graves' disease	9.2e-05	0.00284	CbGpPWpGaD
Mianserin—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	9.17e-05	0.00283	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	9.16e-05	0.00282	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—TSHR—Graves' disease	8.88e-05	0.00274	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—TSHR—Graves' disease	8.84e-05	0.00272	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—TSHR—Graves' disease	8.83e-05	0.00272	CbGpPWpGaD
Mianserin—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.64e-05	0.00266	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	8.59e-05	0.00265	CbGpPWpGaD
Mianserin—SLC6A4—SIDS Susceptibility Pathways—IL1B—Graves' disease	8.49e-05	0.00262	CbGpPWpGaD
Mianserin—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	8.32e-05	0.00256	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—TSHR—Graves' disease	8.02e-05	0.00247	CbGpPWpGaD
Mianserin—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.88e-05	0.00243	CbGpPWpGaD
Mianserin—OPRK1—GPCR ligand binding—CXCL10—Graves' disease	7.86e-05	0.00242	CbGpPWpGaD
Mianserin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.8e-05	0.00241	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—TSHR—Graves' disease	7.79e-05	0.0024	CbGpPWpGaD
Mianserin—HTR6—GPCR ligand binding—CXCL10—Graves' disease	7.75e-05	0.00239	CbGpPWpGaD
Mianserin—HTR7—GPCR ligand binding—CXCL10—Graves' disease	7.74e-05	0.00239	CbGpPWpGaD
Mianserin—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	7.69e-05	0.00237	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—TSHR—Graves' disease	7.67e-05	0.00236	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—TSHR—Graves' disease	7.65e-05	0.00236	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	7.64e-05	0.00236	CbGpPWpGaD
Mianserin—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.53e-05	0.00232	CbGpPWpGaD
Mianserin—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.49e-05	0.00231	CbGpPWpGaD
Mianserin—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	7.45e-05	0.0023	CbGpPWpGaD
Mianserin—HRH4—GPCR downstream signaling—CXCL10—Graves' disease	7.36e-05	0.00227	CbGpPWpGaD
Mianserin—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.36e-05	0.00227	CbGpPWpGaD
Mianserin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.29e-05	0.00225	CbGpPWpGaD
Mianserin—DRD2—Circadian rythm related genes—FAS—Graves' disease	7.25e-05	0.00223	CbGpPWpGaD
Mianserin—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	7.07e-05	0.00218	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	6.98e-05	0.00215	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—TSHR—Graves' disease	6.88e-05	0.00212	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	6.82e-05	0.0021	CbGpPWpGaD
Mianserin—HTR1F—GPCR downstream signaling—CXCL10—Graves' disease	6.8e-05	0.0021	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—TSHR—Graves' disease	6.78e-05	0.00209	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—TSHR—Graves' disease	6.77e-05	0.00209	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	6.73e-05	0.00207	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—CXCL10—Graves' disease	6.69e-05	0.00206	CbGpPWpGaD
Mianserin—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.61e-05	0.00204	CbGpPWpGaD
Mianserin—DRD3—GPCR ligand binding—CXCL10—Graves' disease	6.58e-05	0.00203	CbGpPWpGaD
Mianserin—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.51e-05	0.00201	CbGpPWpGaD
Mianserin—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.49e-05	0.002	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—TSHR—Graves' disease	6.24e-05	0.00193	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	6.19e-05	0.00191	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—CXCL10—Graves' disease	6.17e-05	0.0019	CbGpPWpGaD
Mianserin—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	6.16e-05	0.0019	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—TSHR—Graves' disease	6.15e-05	0.0019	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—TSHR—Graves' disease	6.15e-05	0.0019	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TSHR—Graves' disease	6.11e-05	0.00188	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—TSHR—Graves' disease	6.11e-05	0.00188	CbGpPWpGaD
Mianserin—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	5.98e-05	0.00184	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	5.94e-05	0.00183	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	5.92e-05	0.00183	CbGpPWpGaD
Mianserin—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.91e-05	0.00182	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—TSHR—Graves' disease	5.76e-05	0.00177	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	5.74e-05	0.00177	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—CXCL10—Graves' disease	5.71e-05	0.00176	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	5.71e-05	0.00176	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TSHR—Graves' disease	5.64e-05	0.00174	CbGpPWpGaD
Mianserin—HRH4—GPCR downstream signaling—IL2RA—Graves' disease	5.63e-05	0.00174	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—TSHR—Graves' disease	5.62e-05	0.00173	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	5.55e-05	0.00171	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—TSHR—Graves' disease	5.23e-05	0.00161	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	5.2e-05	0.0016	CbGpPWpGaD
Mianserin—HTR1F—GPCR downstream signaling—IL2RA—Graves' disease	5.19e-05	0.0016	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—CXCL10—Graves' disease	5.19e-05	0.0016	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—IL2RA—Graves' disease	5.11e-05	0.00158	CbGpPWpGaD
Mianserin—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.11e-05	0.00158	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—CXCL10—Graves' disease	5.04e-05	0.00155	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	5.02e-05	0.00155	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.99e-05	0.00154	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	4.99e-05	0.00154	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GC—Graves' disease	4.96e-05	0.00153	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	4.96e-05	0.00153	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	4.95e-05	0.00152	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	4.95e-05	0.00152	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—CXCL10—Graves' disease	4.95e-05	0.00152	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	4.85e-05	0.0015	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TSHR—Graves' disease	4.74e-05	0.00146	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	4.72e-05	0.00145	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL2RA—Graves' disease	4.72e-05	0.00145	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—TSHR—Graves' disease	4.56e-05	0.0014	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—TSHR—Graves' disease	4.53e-05	0.0014	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	4.51e-05	0.00139	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—CXCL10—Graves' disease	4.44e-05	0.00137	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	4.41e-05	0.00136	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—TSHR—Graves' disease	4.4e-05	0.00136	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	4.38e-05	0.00135	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	4.37e-05	0.00135	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—IL2RA—Graves' disease	4.36e-05	0.00135	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	4.35e-05	0.00134	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	4.33e-05	0.00134	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—TSHR—Graves' disease	4.32e-05	0.00133	CbGpPWpGaD
Mianserin—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	4.29e-05	0.00132	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—IL2RA—Graves' disease	4.06e-05	0.00125	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—CXCL10—Graves' disease	4.04e-05	0.00124	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GC—Graves' disease	4.03e-05	0.00124	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—TSHR—Graves' disease	4e-05	0.00123	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	4e-05	0.00123	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—CXCL10—Graves' disease	3.98e-05	0.00123	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—CXCL10—Graves' disease	3.97e-05	0.00122	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL2RA—Graves' disease	3.96e-05	0.00122	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CXCL10—Graves' disease	3.95e-05	0.00122	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	3.95e-05	0.00122	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	3.94e-05	0.00122	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—TSHR—Graves' disease	3.94e-05	0.00121	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—TSHR—Graves' disease	3.93e-05	0.00121	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—IL2RA—Graves' disease	3.79e-05	0.00117	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GC—Graves' disease	3.78e-05	0.00116	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—B3GNT2—Graves' disease	3.76e-05	0.00116	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	3.72e-05	0.00115	CbGpPWpGaD
Mianserin—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	3.71e-05	0.00114	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TSHR—Graves' disease	3.69e-05	0.00114	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CXCL10—Graves' disease	3.65e-05	0.00112	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TSHR—Graves' disease	3.64e-05	0.00112	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TSHR—Graves' disease	3.63e-05	0.00112	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	3.63e-05	0.00112	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TSHR—Graves' disease	3.61e-05	0.00111	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	3.58e-05	0.0011	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—IL2RA—Graves' disease	3.4e-05	0.00105	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—CXCL10—Graves' disease	3.38e-05	0.00104	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	3.36e-05	0.00104	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	3.35e-05	0.00103	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	3.34e-05	0.00103	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	3.32e-05	0.00102	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TSHR—Graves' disease	3.32e-05	0.00102	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	3.24e-05	0.000999	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	3.23e-05	0.000994	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	3.14e-05	0.000967	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TSHR—Graves' disease	3.09e-05	0.000952	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL2RA—Graves' disease	3.08e-05	0.000951	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—IL2RA—Graves' disease	3.08e-05	0.00095	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CXCL10—Graves' disease	3.06e-05	0.000944	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	3.06e-05	0.000942	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—B3GNT2—Graves' disease	3.05e-05	0.000941	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	3.05e-05	0.00094	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL2RA—Graves' disease	3.04e-05	0.000937	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL2RA—Graves' disease	3.04e-05	0.000936	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL2RA—Graves' disease	3.02e-05	0.000931	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	3.02e-05	0.00093	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	2.94e-05	0.000908	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	2.93e-05	0.000903	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—B3GNT2—Graves' disease	2.86e-05	0.000882	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	2.85e-05	0.000878	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	2.85e-05	0.000878	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	2.84e-05	0.000876	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	2.8e-05	0.000863	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	2.79e-05	0.000862	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TSHR—Graves' disease	2.79e-05	0.000859	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL2RA—Graves' disease	2.79e-05	0.000859	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	2.77e-05	0.000855	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TSHR—Graves' disease	2.69e-05	0.00083	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TSHR—Graves' disease	2.68e-05	0.000825	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GC—Graves' disease	2.62e-05	0.000809	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TSHR—Graves' disease	2.6e-05	0.000803	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CXCL10—Graves' disease	2.58e-05	0.000797	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL2RA—Graves' disease	2.58e-05	0.000796	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	2.57e-05	0.000791	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	2.55e-05	0.000786	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	2.54e-05	0.000784	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CXCL10—Graves' disease	2.54e-05	0.000782	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	2.48e-05	0.000764	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	2.46e-05	0.00076	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	2.4e-05	0.000739	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL10—Graves' disease	2.38e-05	0.000735	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TSHR—Graves' disease	2.36e-05	0.000728	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL10—Graves' disease	2.35e-05	0.000724	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL10—Graves' disease	2.35e-05	0.000724	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL2RA—Graves' disease	2.34e-05	0.000722	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL10—Graves' disease	2.33e-05	0.000719	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	2.33e-05	0.000719	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TSHR—Graves' disease	2.32e-05	0.000717	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TSHR—Graves' disease	2.32e-05	0.000715	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	2.31e-05	0.000713	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	2.25e-05	0.000694	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	2.24e-05	0.00069	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GC—Graves' disease	2.22e-05	0.000686	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	2.18e-05	0.000671	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	2.18e-05	0.000671	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL10—Graves' disease	2.14e-05	0.000661	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	2.14e-05	0.00066	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	2.14e-05	0.000659	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TSHR—Graves' disease	2.12e-05	0.000652	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL10—Graves' disease	2e-05	0.000615	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—B3GNT2—Graves' disease	1.99e-05	0.000613	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL2RA—Graves' disease	1.98e-05	0.000609	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	1.95e-05	0.0006	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	1.94e-05	0.000599	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL2RA—Graves' disease	1.94e-05	0.000598	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2RA—Graves' disease	1.82e-05	0.000562	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	1.8e-05	0.000555	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2RA—Graves' disease	1.8e-05	0.000554	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2RA—Graves' disease	1.79e-05	0.000553	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2RA—Graves' disease	1.78e-05	0.000549	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	1.77e-05	0.000545	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL10—Graves' disease	1.74e-05	0.000536	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL10—Graves' disease	1.73e-05	0.000533	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GC—Graves' disease	1.72e-05	0.000529	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—B3GNT2—Graves' disease	1.69e-05	0.00052	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	1.68e-05	0.000519	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2RA—Graves' disease	1.64e-05	0.000505	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL10—Graves' disease	1.53e-05	0.000471	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2RA—Graves' disease	1.53e-05	0.00047	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL10—Graves' disease	1.5e-05	0.000463	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL10—Graves' disease	1.5e-05	0.000462	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	1.38e-05	0.000424	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	1.37e-05	0.000421	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2RA—Graves' disease	1.33e-05	0.00041	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2RA—Graves' disease	1.32e-05	0.000408	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.3e-05	0.000401	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	1.29e-05	0.000397	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2RA—Graves' disease	1.17e-05	0.00036	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2RA—Graves' disease	1.15e-05	0.000354	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2RA—Graves' disease	1.15e-05	0.000353	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	1.04e-05	0.000322	CbGpPWpGaD
